Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure

Background and Methods:Limited data are available on the safety of fingolimod in pregnant women. We estimated the risk of adverse pregnancy outcomes in women with multiple sclerosis (MS) exposed to fingolimod either shortly before or during pregnancy in prospectively collected cases from clinical trials, observational studies, surveillance programs, and spontaneous reports. Results:The prevalence of major malformations among live births does not...